As always, Janssen remains committed to healthcare professionals and patients, as well as to our employees and communities

COVID-19 Coronavirus Infections

Title

Covid19

This new series of educational interviews from Johnson & Johnson presented by journalist Lisa Ling aims to explore the #COVID19 vaccine development process and to better understand the work of the scientific community. It also takes a closer look at the complex process of vaccine development. Each week, she hosts discussions with scientists and researchers, health professionals and public health experts from around the world who are working together to end this pandemic. Click here for all episodes.

For COVID-19 related press questions,click here.

WHAT IS THE RESPONSE OF JANSSEN TO THE COVID-19 PANDEMIC?

1. Accelerating the development
of a vaccine for COVID-19

2. Screen a library of antiviral molecules in collaboration with partners to help identify
potential treatments for the virus

3. We contribute to
COVID-19 tests in Belgium

4. We produced desinfectant hand liquid to address
hospital shortages in the fight against the coronavirus

5. In addition to our core tasks, we offer our employees the opportunity to volunteer

WHAT IMPACT DOES COVID-19 HAVE ON US AS A COMPANY?

With the Johnson & Johnson family, we’ve worked out a robust business continuity plan
to keep our business going

Latest press releases

Johnson & Johnson Announces a Lead Vaccine Candidate for COVID-19; Landmark New Partnership with U.S. Department of Health & Human Services; and Commitment to Supply One Billion Vaccines Worldwide for Emergency Pandemic Use